← FDA Drug Approvals (Drugs@FDA)
PROGESTERONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2026-10-16
Drug application
- FDA Application #
ANDA219588- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PROGESTERONE
- Generic name
- Progesterone
- Active ingredients
- PROGESTERONE
- Dosage form
- INSERT
- Route
- VAGINAL
- Marketing status
- Prescription
- Sponsor
- NOVAST LABS
- First approval
- 2026-10-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown